Full text is available at the source.
Abstract
Glucagon-like peptide-1 receptor agonists are associated with side effects such as dizziness and nausea.
- Increased vagal tone may be linked to the use of GLP-1 receptor agonists.
- The study explored the relationship between GLP-1 RA use and vagal activity-related events.
- Findings suggest potential implications for patient management regarding these side effects.
Simplified